MYUNG IN PHARMA CO LTD

Myung In Pharmaceutical LTD. is a pharmaceutical company that manufactures both ETC and OTC drugs. Its product areas include thrombosis and anti-platelet, anti-hypertensive, anti-angina, anti-parkinson, anti-dementia, anti-epileptics, anti-schizophrenia, anti-depressants, ADHD, anti-insomnia, gum disease treatment, gastrointestinal, cold-cough medicine, anti-fever, anti-pain, anti-inflammation, nutrition supplements, and other pharmaceuticals. The company also provides APIs such as benztropine mesylate, benidipine HCl, clopidogrel bisulfate, haloperidol, paroxetine HCl, pimozide, quetiapine fumarate, rasagiline mesylate, risperidone, sumatriptan succinate, trazodone HCl, triazolam, levetiracetam, carbamazepine, benserazide hydrochloride, escitalopram oxalate, vortioxetine HBr, brivaracetam, edoxaban tosylate, opicapone, brexpiprazole, guanfacine hydrochloride, lacosamide, and lurasidone hydrochloride. Founded in 1985, Myung In Pharmaceutical LTD. is based in Hwaseong-si, South Korea.